RecruitingNCT05888987

Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection

Use of a New Rapid Multiplex PCR System for the Microbiological Diagnosis of Severe Infectious Keratitis: Impact on Therapeutic Management (ABCORFILM Study)


Sponsor

CHU de Reims

Enrollment

46 participants

Start Date

Jul 7, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Microbial keratitis is a severe and often blindness-inducing pathology which represents today the first reason for long-term hospitalization (more than 5 days) in ophthalmology. Its diagnosis is clinical and leads to an immediate hospitalization in the presence of serious criteria (Mackie classification). The entire process of microbiological diagnosis requires several days before etiological confirmation and therefore delays the initiation of targeted therapy. Recently, new PCR systems allowing the detection of 18 to 27 pathogens in 75 minutes have been developed. Their use could thus be transposed to ophthalmology by adapting the microbiological diagnostic technique to samples currently taken by swabbing the cornea. The investigators will compare their diagnosis performance versus conventional methods on patients who suffered for a microbial keratitis with severity criteria.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Over 18 years old
  • With social security affiliation
  • Willing to participate this study
  • Hospitalized in our department for severe infectious keratitis
  • Any prior (48 hours) or concomitant treatment with local or systemic antibiotherapy at time of corneal scrapping and swabbing
  • Patient not covered by the French Health Insurance
  • Unable to give informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALPCR multiplex by FilmArray

PCR multiplex by FilmArray system on corneal swabbing sample


Locations(1)

Damien JOLLY

Reims, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05888987


Related Trials